Viewing Study NCT05890222



Ignite Creation Date: 2024-05-06 @ 7:06 PM
Last Modification Date: 2024-10-26 @ 3:00 PM
Study NCT ID: NCT05890222
Status: RECRUITING
Last Update Posted: 2024-05-30
First Post: 2023-05-12

Brief Title: IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion
Sponsor: Sangath
Organization: Sangath

Study Overview

Official Title: IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IMPRESS
Brief Summary: The goal of this Hybrid Type 2 Implementation-Effectiveness Cluster Randomised Controlled Trial is to reduce the treatment gap for depression through the integrated implementation of interventions in facility and community platforms in Goa India The primary question is to examine whether a community intervention Community Model enhances the demand for and improves the outcomes of an evidence-based brief psychological treatment for depression delivered by non-specialist health workers in primary health care facilities Facility Model Participants in the Facility Model arm will receive only a psychosocial intervention for depression the Healthy Activity Program - HAP while participants in the Community Model will receive both the HAP and the community intervention We will compare the Facility Model and the Community Model to assess if the latter is superior in increasing the demand for depression treatment in primary care increasing uptake of treatment by people with depression increasing treatment completion rates and reducing the severity of depression
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None